Full text is available at the source.
Abstract
Pharmacologic clearance of senescent cells with the compound 753b reverses key aging markers in hematopoietic stem cells.
- The aging hematopoietic system shows impaired stem cell function and increased vulnerability to conditions like anemia and infections.
- Treatment with 753b restores balanced lineage output and reverses several functional characteristics of hematopoietic aging.
- Single-cell RNA sequencing indicates that 753b reduces aging-related gene activity in hematopoietic stem cells.
- 753b selectively removes senescent, pro-survival niche cells while maintaining overall niche composition.
- The compound also decreases inflammatory signals from both niche and hematopoietic cells, promoting a healthier bone marrow environment.
Simplified